Literature DB >> 19387104

Risk of incident Alzheimer's disease in diabetic patients: a systematic review of prospective trials.

Daniel Kopf1, Lutz Frölich.   

Abstract

Diabetes mellitus is an established risk factor of cognitive decline. This excess risk has frequently been attributed to cerebrovascular disease. The contribution of diabetes mellitus to the risk of Alzheimer's disease is less clear. We performed a systematic literature review based on prospective studies that examined the risk of incident Alzheimer's disease in diabetic patients. Fourteen studies in eleven different populations fulfilled the entry criteria. Only one study per population was included by pre-defined criteria, leaving eleven studies for analysis. All studies reported risk ratios greater than one (median 1.59, range 1.15-2.7). In four studies, this excess risk was statistically significant (median 1.73, range 1.59-1.9); in seven studies the lower border of the 95% confidence interval was below 1.0. Factors associated with significant results were a sample size of 600 or more diabetic subjects, inclusion of patients with mild glycemic dysregulation as assessed by oral glucose tolerance test, and a high proportion of diagnoses of Alzheimer's disease verified by autopsy or magnetic resonance imaging. Diabetes mellitus is likely to increase the risk of Alzheimer's disease. The association of Alzheimer's disease and diabetes mellitus is more clear-cut, if mild cases of diabetes mellitus are included in the analysis.

Entities:  

Mesh:

Year:  2009        PMID: 19387104     DOI: 10.3233/JAD-2009-1011

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  58 in total

Review 1.  Is Alzheimer's disease amyloidosis the result of a repair mechanism gone astray?

Authors:  Tyler A Kokjohn; Chera L Maarouf; Alex E Roher
Journal:  Alzheimers Dement       Date:  2011-11-02       Impact factor: 21.566

Review 2.  Type 2 diabetes mellitus, dyslipidemia, and Alzheimer's disease.

Authors:  Cynthia M Carlsson
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

3.  Intracerebroventricular streptozotocin exacerbates Alzheimer-like changes of 3xTg-AD mice.

Authors:  Yanxing Chen; Zhihou Liang; Zhu Tian; Julie Blanchard; Chun-Ling Dai; Sonia Chalbot; Khalid Iqbal; Fei Liu; Cheng-Xin Gong
Journal:  Mol Neurobiol       Date:  2013-08-31       Impact factor: 5.590

4.  [Diabetes and dementia].

Authors:  A Bahrmann; P Bahrmann; T Kubiak; D Kopf; P Oster; C C Sieber; W G Daniel
Journal:  Z Gerontol Geriatr       Date:  2012-01-27       Impact factor: 1.281

Review 5.  The Aβ oligomer hypothesis for synapse failure and memory loss in Alzheimer's disease.

Authors:  Sergio T Ferreira; William L Klein
Journal:  Neurobiol Learn Mem       Date:  2011-09-06       Impact factor: 2.877

6.  Preliminary results of highly localized plantar irradiation with low incident levels of mid-infrared energy which contributes to the prevention of dementia associated with underlying diabetes mellitus.

Authors:  Kenji Ryotokuji; Keisou Ishimaru; Kazuhiko Kihara; Takuma Nakajima; Satoru Otani; Yoshihisa Namiki
Journal:  Laser Ther       Date:  2015-03-31

7.  Effects of Undaria pinnatifida (Wakame) on Postprandial Glycemia and Insulin Levels in Humans: a Randomized Crossover Trial.

Authors:  Keiko Yoshinaga; Rieko Mitamura
Journal:  Plant Foods Hum Nutr       Date:  2019-12       Impact factor: 3.921

8.  [Diabetes mellitus and dementia].

Authors:  D Kopf
Journal:  Internist (Berl)       Date:  2015-05       Impact factor: 0.743

9.  The impact of dietary energy intake on cognitive aging.

Authors:  Mark P Mattson
Journal:  Front Aging Neurosci       Date:  2010-03-08       Impact factor: 5.750

10.  Short-Term Alterations in Behavior and Astroglial Function After Intracerebroventricular Infusion of Methylglyoxal in Rats.

Authors:  Lílian Juliana Lissner; Leticia Rodrigues; Krista Minéia Wartchow; Ederson Borba; Larissa Daniele Bobermin; Fernanda Urruth Fontella; Fernanda Hansen; André Quincozes-Santos; Diogo Onofre Gomes Souza; Carlos-Alberto Gonçalves
Journal:  Neurochem Res       Date:  2020-10-23       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.